Teva Stops Selling Generic Univasc
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement with Schwarz ends at-risk launch of the antihypertensive moexipril. Teva launched the generic in May 2003 after receiving a favorable patent ruling in federal district court.